Skip to content. | Skip to navigation

Garvan Institute

Sections
 

Dr Robert Brink

 

Senior Research Fellow; Group leader, B Cell Immunobiology, Immunology Program, Garvan Institute of Medical Research

Email: r.brink 'at' garvan.org.au
Research Group: B Cell Immunobiology

 
 
Robert first became interested in immunology as an undergraduate upon learning of the incredible processes by which B cells rearrange and mutate their immunoglobulin genes in order to generate antibody diversity. After completing his PhD on B cell activation and self-tolerance, he was awarded a CJ Martin Overseas Biomedical Fellowship in 1994.
 
 
 

Robert undertook his postdoctoral studies at the Whitehead Institute in Boston, where he furthered his molecular skills and worked on TNF receptors their signalling molecules. Upon returning to Australia, he generated gene-targeted mice designed with which to visualise B cell responses and analyse gene function in vivo. Robert joined Garvan as a Senior Research Fellow in 2006 and continues to use these in vivo models to uncover how B cells function during protective immune responses, autoimmune disease and lymphomagenesis.

 

Selected Publications

Chan TD, Gatto D, Wood K, Camidge T, Basten A and Brink R (2009) Antigen affinity controls rapid T-dependent antibody production by driving the expansion rather than the differentiation or extrafollicular migration of early plasmablasts. J. Immunol. 183: 3139-3149.

Gatto D, Paus D, Basten A, Mackay C and Brink R (2009) Guidance of B cells by the orphan G protein-coupled receptor EBI2 shapes humoral immune responses. Immunity. 31: 259-269.

Gardam S, Sierro F, Basten A, Mackay F and Brink R (2008) TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor. Immunity. 28: 391-401.

Brink R, Phan TG, Paus, D and Chan TD (2008) Visualising the effects of antigen affinity on T-dependent B cell differentiation. Immunol. Cell Biol. 86: 31-39.

Vince JE, Wong WW, Khan N, Feltham R, Chau, D, Ahmed AU, Chan D, Benetatos CA, Chunduru SK, Condon SM, McKinlay M, Brink R, Leverkus M, Tergaonkar V, Schneider P, Callus BA, Koentgen F, Vaux DL and Silke J. (2007) IAP antagonists target cIAP1 to induce TNF-dependent apoptosis. Cell. 131: 682-693.

Brink R. (2007) Germinal-center B cells in the zone. Immunity. 26: 552-554.

Phan TG, Paus D, Chan TD, Turner ML, Nutt SL, Basten A and Brink R. (2006). High affinity germinal center B cells are actively selected into the plasma cell compartment. J. Exp. Med. 203: 2419-2424.

Paus D, Phan TG, Chan TD, Gardam, S, Basten A and Brink R. (2006) Antigen recognition strength regulates the choice between extrafollicular plasma cell and germinal center B cell differentiation. J. Exp. Med. 203: 1081-1091.

Brink R. (2006) Regulation of B cell self-tolerance by BAFF. Sem. Immunol. 18: 276-283.

Grech AP, Gardam S, Chan T, Quinn R, Gonzales R, Basten A and Brink R. (2005) Tumor necrosis factor receptor 2 (TNFR2) signaling is negatively regulated by a novel, carboxyl-terminal TNFR associated factor 2 (TRAF2) binding site. J. Biol. Chem. 280: 31572-31581.

Phan TG, Gardam S, Basten A and Brink R. (2005) Altered migration, recruitment and somatic hypermutation in the early response of marginal zone B cells to T cell-dependent antigen. J. Immunol. 174: 4567-4578.

Grech AP, Amesbury M, Chan T, Gardam S, Basten A and Brink R. (2004) TRAF2 differentially regulates the canonical and non-canonical pathways of NF-B activation in mature B cells. Immunity. 21: 629-642.

Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F and Brink R. (2004) Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 20: 785-798.

Phan TG, Amesbury M, Gardam S, Crosbie J, Hasbold J, Hodgkin PD, Basten A and Brink R. (2003) B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells. J. Exp. Med. 197: 845-860.

Grech A, Quinn R, Srinivasan D, Badoux X and Brink R. (2000) Complete structural characterisation of the mammalian and Drosophila TRAF genes: implications for TRAF evolution and the role of RING finger splice variants. Mol. Immunol. 37: 721-734.

 

Search for all publications by R Brink

 
 
 

Areas of Interest

Lymphoma, autoantibody-mediated autoimmune diseases, lupus, myasthenia gravis, hemolytic anemia
 

News

 

Mystery solved at crossroads of immune response

MEDIA RELEASE: 17 Jul 2009
Garvan scientists have solved an important mystery about our immune response, a finding that among other things could be used to help improve the body's reaction to vaccination.
 
 

How germs meet their opposites - a mystery revealed in real time

MEDIA RELEASE: 09 Jun 2009
Sophisticated microscope technology has made it possible for Australian and American scientists to record previously unknown interactions between two classes of immune cell right at the beginning of the 'antigen transport chain', the apex of the immune response. An important discovery, this takes us one step further towards being able to control disease and infection.
 
 

B cell mutations that may cause cancers and autoimmune diseases

MEDIA RELEASE: 29 Feb 2008
To remain healthy, we must maintain exactly the right number of B cells, the white blood cells that produce antibodies. Scientists at Garvan have identified the factors critical to maintaining this important balance within our immune systems. When the balance fails, we become prone to developing certain cancers or autoimmune diseases.
 
 

Personal tools